These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16461295)

  • 1. Effects of heparins on hemostatic properties of vascular endothelium.
    Della Porta MG; Malcovati L
    Haematologica; 2006 Feb; 91(2):149a. PubMed ID: 16461295
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential effect of the low-molecular-weight heparin, dalteparin, and unfractionated heparin on microvascular endothelial cell hemostatic properties.
    Vignoli A; Marchetti M; Balducci D; Barbui T; Falanga A
    Haematologica; 2006 Feb; 91(2):207-14. PubMed ID: 16461305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-anticoagulant effects of unfractionated and low-molecular weight heparins.
    Walenga JM
    Clin Adv Hematol Oncol; 2007 Oct; 5(10):759-60. PubMed ID: 17998892
    [No Abstract]   [Full Text] [Related]  

  • 4. Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase.
    Baldus S; Rudolph V; Roiss M; Ito WD; Rudolph TK; Eiserich JP; Sydow K; Lau D; Szöcs K; Klinke A; Kubala L; Berglund L; Schrepfer S; Deuse T; Haddad M; Risius T; Klemm H; Reichenspurner HC; Meinertz T; Heitzer T
    Circulation; 2006 Apr; 113(15):1871-8. PubMed ID: 16606792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of various structural parameters of semisynthetic sulfated polysaccharides on the P-selectin inhibitory capacity.
    Fritzsche J; Alban S; Ludwig RJ; Rubant S; Boehncke WH; Schumacher G; Bendas G
    Biochem Pharmacol; 2006 Aug; 72(4):474-85. PubMed ID: 16780802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the endothelium in cancer--the importance of the interaction of hemostatic mechanisms and the vascular wall for tumor growth and angiogenesis.
    Rickles FR; Patierno SR; Fernandez PM
    Pathophysiol Haemost Thromb; 2003; 33 Suppl 1():1-4. PubMed ID: 12954987
    [No Abstract]   [Full Text] [Related]  

  • 7. Modulatory effects of Escherichia coli capsular-derived sulfaminoheparosans and heparins on tissue factor-mediated activation of platelets: flow cytometric analysis.
    Maddineni J; Jeske WP; Baltasar F; Cornelli U; Manoni M; Hoppensteadt DA; Fareed J
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):311-7. PubMed ID: 16959684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparins inhibit the endothelial pro-thrombotic features induced by tumor cells.
    Vignoli A; Marchetti M; Falanga A
    Thromb Res; 2017 Sep; 157():55-57. PubMed ID: 28692841
    [No Abstract]   [Full Text] [Related]  

  • 9. Heme induces endothelial tissue factor expression: potential role in hemostatic activation in patients with hemolytic anemia.
    Setty BN; Betal SG; Zhang J; Stuart MJ
    J Thromb Haemost; 2008 Dec; 6(12):2202-9. PubMed ID: 18983524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldosterone modifies hemostasis via upregulation of the protein-C receptor in human vascular endothelium.
    Ducros E; Berthaut A; Mirshahi SS; Faussat AM; Soria J; Agarwal MK; Mirshahi M
    Biochem Biophys Res Commun; 2008 Aug; 373(2):192-6. PubMed ID: 18555797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory properties of a heparin-like glycosaminoglycan with reduced anti-coagulant activity isolated from a marine shrimp.
    Brito AS; Arimatéia DS; Souza LR; Lima MA; Santos VO; Medeiros VP; Ferreira PA; Silva RA; Ferreira CV; Justo GZ; Leite EL; Andrade GP; Oliveira FW; Nader HB; Chavante SF
    Bioorg Med Chem; 2008 Nov; 16(21):9588-95. PubMed ID: 18835720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of unfractionated and fractionated heparins on myeloperoxidase activity and interactions with endothelial cells: possible effects on the pathophysiology of equine laminitis.
    de la Rebière G; Franck T; Deby-Dupont G; Salciccia A; Grulke S; Péters F; Serteyn D
    Vet J; 2008 Oct; 178(1):62-9. PubMed ID: 17942351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complications from vascular disrupting agents and angiogenesis inhibitors: aberrant control of hemostasis and thrombosis.
    van Heeckeren WJ; Sanborn SL; Narayan A; Cooney MM; McCrae KR; Schmaier AH; Remick SC
    Curr Opin Hematol; 2007 Sep; 14(5):468-80. PubMed ID: 17934353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Are contrast agents prothrombotic?].
    Imbault P; Aguejouf O; Doutremepuich C
    Ann Cardiol Angeiol (Paris); 1995 Feb; 44(2):98-101. PubMed ID: 7741487
    [No Abstract]   [Full Text] [Related]  

  • 15. Angiogenesis and heparin mimics.
    Weisz PB; Hermann HC; Joullié MM; Kumor K; Levine EM; Macarak EJ; Weiner DB
    EXS; 1992; 61():107-17. PubMed ID: 1377523
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of tissue factor pathway inhibitor in tumor growth and metastasis.
    Amirkhosravi A; Meyer T; Amaya M; Davila M; Mousa SA; Robson T; Francis JL
    Semin Thromb Hemost; 2007 Oct; 33(7):643-52. PubMed ID: 18000790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recollections of the development of flow devices for studying mechanisms of hemostasis and thrombosis in flowing whole blood.
    Sakariassen KS; Turitto VT; Baumgartner HR
    J Thromb Haemost; 2004 Oct; 2(10):1681-90. PubMed ID: 15456474
    [No Abstract]   [Full Text] [Related]  

  • 18. Cancer and thrombosis: from molecular mechanisms to clinical presentations.
    Buller HR; van Doormaal FF; van Sluis GL; Kamphuisen PW
    J Thromb Haemost; 2007 Jul; 5 Suppl 1():246-54. PubMed ID: 17635733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of heparin induced anti-cancer activity in experimental cancer models.
    Niers TM; Klerk CP; DiNisio M; Van Noorden CJ; Büller HR; Reitsma PH; Richel DJ
    Crit Rev Oncol Hematol; 2007 Mar; 61(3):195-207. PubMed ID: 17074500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dydrogesterone on the vascular system.
    Seeger H; Mueck AO
    Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():2-8. PubMed ID: 17943533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.